Yu MC, et al. - In order to assess the performance of the Taiwan multidrug-resistant tuberculosis (MDR-TB) Consortium (TMTC), the data of patients enrolled in its first 5 years was analyzed. Patients, who were usually hospitalized for 1 month initially, were provided with comprehensive care at no cost. Treatment regimens consisted of 4–5 drugs and the duration of treatment was 18–24 months. Each patient was assigned a case manager and a directly observed therapy provider. Observations demonstrate the TMTC to be a highly effective model of care in the management of MDR-TB.